Clinical Trials Directory

Trials / Completed

CompletedNCT05709756

Prevalence and Predictors of Esophageal Thermal Lesions in High-power-Short-duration Ablation of Atrial Fibrillation

Prevalence and Predictors of Esophageal Thermal Lesions in High-Power-Short-Duration Ablation of Atrial Fibrillation

Status
Completed
Phase
Study type
Observational
Enrollment
263 (actual)
Sponsor
Helios Health Institute GmbH · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Patients with documented atrial fibrillation who were referred to our clinic for catheter ablation will undergo standard HPSD ablation and subsequent esophagoscopy. After esophagoscopy patients will be followed up for one month in the form of a telephone follow-up. The primary endpoint of the study assessed by esophagoscopy performed on the day after the index catheter ablaton is the incidence of esophageal thermal lesions. Secondary endpoints include: 1. The size of the esophageal thermal lesions. 2. The severity of esophageal thermal lesions.

Conditions

Timeline

Start date
2021-03-01
Primary completion
2023-08-01
Completion
2023-09-01
First posted
2023-02-02
Last updated
2023-10-02

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT05709756. Inclusion in this directory is not an endorsement.